Though the immune cells appear as if they may be reacting to the tumor, they are likely restrained by PD-L1 signaling, raising the question whether a key impact of anti-PD-L1 agents is to restore activity of infiltrating T cells poised at the tumor margin. Here, CD274 is linked to neoplasm.